# Ajanta Pharma Ltd. – FDA Inspection, Apr 21, 2026

Source: https://www.keypedia.com/records/fda_inspections/ajanta-pharma-ltd/6118c3f9-60aa-44a4-ae82-113ff53e50a0
Source feed: FDA_Inspections

> FDA inspection 1313426 of Ajanta Pharma Ltd., April 21, 2026. 5 citations under 21 CFR part 211. Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1313426
- Company Name: Ajanta Pharma Ltd.
- Inspection Date: 2026-04-21
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 5

## Related Documents

- FDA Inspection 1235564 - 2024-03-05
- [FDA Inspection 1097061 - 2019-06-28](https://www.keypedia.com/records/fda_inspections/ajanta-pharma-ltd/dcc8e789-9501-4bd0-9137-a7594d3fd15c)
- [FDA Inspection 1009806 - 2017-02-07](https://www.keypedia.com/records/fda_inspections/ajanta-pharma-ltd/69d66c75-a99f-42cb-bbb1-29c81e157e1a)
- FDA Inspection 917795 - 2015-03-20
- FDA Inspection 801522 - 2012-09-06

## Related Officers

- [Investigator](https://www.keypedia.com/people/nibin-varghese/43e17f63-2c1f-4d46-b26f-dc8ac8885438)
- [FDA Associated Person](https://www.keypedia.com/people/tamil-arasu/94efc491-7d9f-4221-a1ee-69a925acb1c3)

Company: https://www.keypedia.com/companies/ajanta-pharma-ltd/040efb87-46b2-4747-b87d-c1d87daad1e7

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8
